Global brokerage firm UBS has initiated coverage on as many has half dozen Indian Pharma counters and has suggested to sell four out of them namely, Dr Reddy's, Lupin, Zydus Life and Auro Pharma.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.